̽»¨¾«Ñ¡

I am a doctoral student at the Department of Medical Epidemiology and Biostatistics (MEB), ̽»¨¾«Ñ¡, specializing in health economics. My PhD project focuses on the health economic evaluation of risk-adapted organized prostate cancer testing in Sweden. I am supervised by Dr. Shuang Hao, with co-supervision from Professor Mark Clements, Professor Tobias Nordström, and Professor Anna Lantz. Prior to my doctoral studies, I worked as a healthcare consultant, focusing on the design and conduct of Real-World Evidence studies for pharmaceutical companies. My Master’s thesis, published in a peer-reviewed journal, examined the budget impact of CAR-T cell therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma in Germany.

Education:

• 2021, Public Health, MSc, LMU Munich
• 2019, Business Administration, BSc, LMU Munich

Research Interests:

• Cancer epidemiology
• Health economic modelling and evaluation
• Real-World Evidence generation and application